Every SEC Form 3/4/5 on record for this filer (CIK 1248093) — 1 issuer, 109 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | President & CEO · Director | 2015-11-03 → 2026-04-20 | 59 | −$48M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RARE | 2026-03-02 | Sell | 54,404 | $22.80 | $1M | 658,994 |
| RARE | 2025-03-03 | Sell | 73,434 | $42.10 | $3M | 641,731 |
| RARE | 2025-02-28 | Sell | 25,000 | $42.48 | $1M | 2,158,985 |
| RARE | 2024-12-30 | Sell | 11,727 | $42.23 | $495,231 | 2,183,985 |
| RARE | 2024-12-10 | Sell | 8,273 | $50.00 | $413,650 | 2,195,712 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.